FIELD: medicine.
SUBSTANCE: biotransplant has active ingredient like culture of genetically unmodified neuron trunk cells taken from anterior brain of the first pregnancy trimester human embryo or periventricular region of brain of 15-20 gestation weeks and selectively reproduced under cultivation conditions to the amount of 107-109 pluripotent non-differentiated cells in neurospheres having 50-500 mln of neuron trunk cells and 2 ml of physiologic saline. Method involves introducing 50-500 mln of neuron trunk cells and 2 ml of physiologic saline in one stage in endolumbal way.
EFFECT: enhanced effectiveness of treatment; accelerated repair and improvement of injured brain functions; stable treatment results.
5 cl, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| BIOTRANSPLANT AND METHOD FOR TREATING ISCHEMIC INSULT | 2004 |
|
RU2258521C1 |
| METHOD FOR TREATMENT OF ORGANIC DAMAGE IN CENTRAL NERVOUS SYSTEM BY ENDOLUMBAL TRANSPLANTATION OF HUMAN FETAL CELLS | 2002 |
|
RU2234930C2 |
| TRUNCAL NERVE CELLS, CELLS CULTURE AND BIOTRANSPLANT FOR ALLOTRANSPLANTING AND METHOD FOR PREPARING THE BIOTRANSPLANT | 2001 |
|
RU2191388C1 |
| METHOD OF TREATING VISCERAS | 2012 |
|
RU2495683C1 |
| METHOD OF TREATMENT OF PATIENTS WITH DEMYELINIZING DISEASES | 1998 |
|
RU2139717C1 |
| PRODUCTION OF TERMINAL-DIFFERENTIATED DOFAMINNERGIC NEURONES FROM EMBRIONIC HUMAN FOUNDER CELLS | 2004 |
|
RU2345133C2 |
| BIOTRANSPLANT AND METHOD FOR TREATING MENTAL DEVELOPMENT DELAY CASES | 2006 |
|
RU2303462C1 |
| EVALUATION METHOD OF MORPHOFUNCTIONAL STATE OF INDUCED PLURIPOTENT STEM CELLS OF PARKINSONIAN PATIENTS, WHICH ARE DIFFERENTIATED TO DOPAMINERGIC NEURONS | 2012 |
|
RU2501853C1 |
| METHOD FOR PRODUCTION OF CELL CULTURE FOR TREATMENT OF VASCULAR DEMYELINATING DISEASES OF NERVOUS SYSTEM AND CELL CULTURE PRODUCED BY THIS METHOD (VERSIONS) | 2007 |
|
RU2347579C1 |
| BIOMEDICAL CELL PRODUCT FOR TREATING NERVOUS DISEASES AND MENTAL DISORDERS, METHOD FOR PRODUCTION THEREOF AND USE THEREOF | 2018 |
|
RU2720002C1 |
